This is announced by the Schall law firm

LOS ANGELES, May 10, 2024 (GLOBE NEWSWIRE) — Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in MacroGenics, Inc. (“MacroGenics” or “the Company”). (NASDAQ: MGNX) for violations of securities laws.

The investigation will focus on whether the Company made false and/or misleading statements and/or failed to disclose information relevant to investors. MacroGenics provided investors with a clinical trial update as part of its recent earnings report, admitting that five patients had died during the TAMARACK trial. On this news, shares of MacroGenics fell more than 70% on May 10, 2024.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights free of charge. You can also reach us via the company’s website at www.schallfirm.com or by email at [email protected].

The Schall Law Firm represents investors throughout the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered attorney advertising in some jurisdictions under applicable law and ethical rules.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]

www.schallfirm.com